A new tool can identify cells that are actively responding to a SARS-CoV-2 infection. As reported in "Science Advances" by the Gargiulo lab, it can be used to screen for effective COVID-19 therapies and can be tailored to study other viruses as well.
OMEICOS, a biopharmaceutical company developing first-in-class small molecule therapeutics based on the profound understanding of omega-3 fatty acid metabolism and physiology, announced today that the Company has received a significant grant by the…
The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max…
Genome Architecture Mapping captures complex, multi-way interactions in the genome. This is different than the workhorse technique of 3D genomics, which sees mostly two-way contacts, finds a new study by a team led by Ana Pombo from the Max Delbrück…
What could healthcare look like in 10, 20, or 30 years? What will be the future of healthcare? Will medical professionals make diagnoses with the aid of artificial intelligence? Will doctors use big data analytics to predict the course of diseases?…
Berlin-Brandenburg is one of the leading international life science locations. Here and throughout Germany, the healthcare industry is growing steadily. Suitable areas for research and development as well as production will therefore be needed more…
In combination with BIOTRONIK Home Monitoring® the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden
Sweet code with laser printing - A team of researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) has developed a method that could make it more difficult to counterfeit products in the future. The new and patented method makes it…
A mutation that causes severe hypertension also protects the kidneys from being damaged, reports a team led by Enno Klußmann of the Max Delbrück Center and the DZHK in “Kidney International”. The researchers are now exploring how the effects of the…
While CAR-T cells have proven successful in treating certain types of leukemia and lymphoma, these immunotherapies can become even more effective. A clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million…
